Cargando…
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
OBJECTIVES: To characterise the use of the parenteral non-steroidal anti-inflammatory drug parecoxib when given by continuous subcutaneous infusion (CSCI) in a hospice population. Clinical experience suggests parecoxib CSCI may be of benefit in this population, but empirical evidence in relation to...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867430/ https://www.ncbi.nlm.nih.gov/pubmed/28864447 http://dx.doi.org/10.1136/bmjspcare-2017-001348 |